About MedReg Intel

MedReg Intel is an independent platform dedicated to medical device regulatory intelligence in India, focusing on the interpretation and practical understanding of regulatory frameworks such as the Medical Device Rules (MDR) 2017, CDSCO approval pathways, and quality system requirements for medical technology companies.

The objective of MedReg Intel is to simplify complex regulatory processes and provide structured insights that help medical device manufacturers, importers, startups, and regulatory professionals better understand how regulatory decisions affect market entry and compliance in India.

This platform publishes practical articles and analysis on topics such as:

• Medical Device Import Licensing (MD-14, MD-15)

• Device classification under MDR 2017

• CDSCO regulatory pathways and documentation requirements

• Device Master File (DMF) and Plant Master File (PMF) preparation

• ISO 13485 quality system considerations

• Regulatory strategy for medical device startups and importers

Rather than focusing only on theory, MedReg Intel aims to explain how regulatory submissions actually work in practice, including common documentation gaps, regulatory queries, and approval challenges faced by companies navigating Indian medical device regulations.

About the Author

Ankur K. Khare
Biomedical Engineer | Regulatory Affairs Specialist | Founder – MedReg Intel

Ankur Khare holds a Master’s degree in Biomedical Engineering and has professional exposure to healthcare systems and medical technology environments.

His work focuses on understanding and analyzing regulatory pathways for medical devices in India, particularly in relation to:

• CDSCO regulatory approvals and submission pathways

• Medical Device Rules (MDR) 2017 implementation

• Import licensing for moderate-to-high risk medical devices

• Documentation frameworks such as Device Master File (DMF) and Plant Master File (PMF)

• Regulatory readiness for medical device startups and importers

Through MedReg Intel, he aims to build a knowledge resource that provides clear, structured regulatory insights to help professionals better understand regulatory expectations before submission.

Mission of MedReg Intel

The mission of MedReg Intel is to create a reliable regulatory intelligence resource for the medical device ecosystem in India.

By combining engineering understanding with regulatory analysis, the platform seeks to support:

• Medical device startups entering the Indian market

• Importers navigating CDSCO regulatory pathways

• Regulatory professionals seeking structured insights

• Healthcare technology companies preparing for compliance under MDR 2017

MedReg Intel aims to contribute to better understanding of regulatory processes that ultimately support safe, compliant, and responsible medical device innovation.

Regulatory Consulting & Collaboration

MedReg Intel also examines regulatory considerations relevant to emerging medical technologies and evolving compliance frameworks.

Areas of focus include:

• Medical device regulatory pathway analysis

• MDR 2017 compliance understanding

• Documentation readiness considerations

• Regulatory intelligence for medical technology companies

Discussions and professional collaboration are welcome with medical device founders, regulatory teams, and healthcare technology professionals working within the Indian regulatory ecosystem.

Connect

Website: www.medregintel.com

LinkedIn: www.linkedin.com/in/ankur-khare-6aa93a147

Connect with the author for professional discussions related to medical device regulation, regulatory strategy, and compliance frameworks in India.

Disclaimer

MedReg Intel is an independent regulatory intelligence platform and is not affiliated with CDSCO, the Government of India, or any regulatory authority.


The information provided on this website is intended for educational and informational purposes and should not be interpreted as official regulatory advice.

Comments

Post a Comment

Popular posts from this blog

A Practical Roadmap for Developing Medical Devices in India

A Practical Roadmap for Developing Medical Devices in India From Idea to Market — Without Costly Regulatory Mistakes By Ankur K. Khare – Biomedical Engineer | Regulatory Affairs Specialist | AI Ethics & Medical Innovation Developing a medical device in India is not just an engineering challenge. It is a regulatory, clinical, manufacturing, and ethical journey — and most failures happen not because the product is bad, but because the roadmap is wrong . Too many teams build first and think about regulation later. By the time CDSCO enters the picture, timelines are already broken. This guide lays out a clear, India-specific roadmap for medical device development — grounded in MDR 2017, CDSCO scrutiny patterns, and real-world failures — so teams can build right , not just fast. Why This Matters An incorrect development sequence can: Delay approvals by months Multiply compliance costs Force redesigns late in the lifecycle Undermine regulatory credibility Most of this is preventable —...
Read more

How to Classify Medical Devices in India (Class A, B, C & D) – MDR 2017 Guide

Medical Device Classification in India Class A, B, C & D — Practically Explained Under MDR 2017 By Ankur K. Khare – Biomedical Engineer | Regulatory Affairs Specialist | AI Ethics & Medical Innovation Medical device classification in India is not paperwork. It is the single decision that determines: Your regulatory pathway Your documentation burden Your clinical evidence requirements Your approval timelines Your compliance cost Under the Medical Device Rules (MDR), 2017 , every medical device is classified into Class A, B, C, or D based on risk. Misclassify your device — and everything downstream becomes unstable. This article explains classification practically , not just legally. Why Classification Matters More Than You Think Your classification affects: Whether you apply to State or Central authority Which forms you submit (MD-5, MD-9, MD-14, etc.) Whether clinical investigation is required How intense CDSCO scrutiny will be Post-market obligations ⚠️ Common Founder Mistake...
Read more

BMMP in India: How ₹4,564 Crore Broken Equipment Became Life-Saving Assets

The Ultimate Guide to Biomedical Equipment Maintenance Programs (BMMP) in India: Complete Analysis, KPIs & Dashboard Design By Ankur K. Khare – Biomedical Engineer | AI Ethics & Medical Innovation How India transformed ₹4,564 crore worth of dysfunctional medical equipment into life-saving assets—and the blueprint to replicate this success in any state The Revolutionary BMMP Story: From Crisis to Success The Shocking Reality (Pre-2015) Before 2015, India's healthcare infrastructure was facing a critical equipment crisis: ·          7,56,750 medical equipment units scattered across 29,115 health facilities ·          ₹4,564 crores worth of equipment identified through comprehensive mapping ·          13-34% dysfunctional rate across different states ·          No systematic maintenance framework in place...
Read more